SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-034623
Filing Date
2024-08-30
Accepted
2024-08-30 17:04:02
Documents
13
Period of Report
2024-08-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37562
  Complete submission text file 0001493152-24-034623.txt   211437

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE evfm-20240828.xsd EX-101.SCH 3009
3 XBRL LABEL FILE evfm-20240828_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE evfm-20240828_pre.xml EX-101.PRE 24161
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3587
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 241270952
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)